Radiomics and machine learning applications in rectal cancer: Current update and future perspectives
Authors:
- Arnaldo StanzioneASArnaldo Stanzione
- Francesco VerdeFVFrancesco Verde
- Valeria RomeoVRValeria Romeo
- Francesca BoccadifuocoFBFrancesca Boccadifuoco
- Pier Paolo MainentiPMPier Paolo Mainenti
- Simone MaureaSMSimone Maurea
Open Access
- 28 August 2021
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 27 (32) , 5306-5321
Abstract
Radiomics and machine learning applications in rectal cancer: Current update and future perspectivesKeywords
This publication has 116 references indexed in Scilit:
- Radiomics: Images Are More than Pictures, They Are DataRadiology, 2016
- Diffusion volume (DV) measurement in endometrial and cervical cancer: A new MRI parameter in the evaluation of the tumor grading and the risk classificationEuropean Journal of Radiology, 2015
- Rectal cancer: An evidence-based update for primary care providersWorld Journal of Gastroenterology, 2015
- Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trialsAnnals of Oncology, 2014
- Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approachNature Communications, 2014
- Mutations of KRAS and PIK3CA as independent predictors of distant metastases in colorectal cancerMedical Oncology, 2014
- Mandard Tumour Regression Grade, Perineural Invasion, Circumferential Resection Margin and Post-chemoradiation Nodal Status Strongly Predict Outcome in Locally Advanced Rectal Cancer Treated with Preoperative ChemoradiotherapyClinical Oncology, 2014
- Multimodal imaging evaluation in staging of rectal cancerWorld Journal of Gastroenterology, 2014
- Poorly Differentiated Colorectal CancersAmerican Journal of Clinical Pathology, 2013
- Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient dataThe Lancet Oncology, 2010